載入...

A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation

BACKGROUND: The purpose of this study was to test the efficacy and safety of daclizumab (DZM) versus anti-thymocyte globulin (ATG) as a component of induction therapy in heart transplant recipients. METHODS: Thirty heart transplant patients were randomized to receive either ATG or DZM during inducti...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Mullen, John C, Kuurstra, Emily J, Oreopoulos, Antigone, Bentley, Michael J, Wang, Shaohua
格式: Artigo
語言:Inglês
出版: BioMed Central 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120716/
https://ncbi.nlm.nih.gov/pubmed/25093077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-1440-3-14
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!